Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Genetic Technologies Ltd.

Make the COVID-19 PRS test commercially available

Delivered after the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
28 Jan 2021
Due
31 Mar 2021
Delivered
May 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“COVID-19 PRS test is undergoing technical validation with an expanded data set and is expected to be commercially available by the end of Q1 CY21”

What we found

Evidence strength A What the grades mean

The company failed to make the test commercially available by the Q1 2021 deadline, subsequently pushing the expected commercial release date to the end of May 2021.

  • A
    Genetic Technologies Ltd. 6-K filed 2021-04-09 Regulatory filing · published 9 Apr 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint c50ecdb64eea
    “IBX, our US based distribution partner is currently completing the technical interface with their telehealth partner for the commercial availability of the COVID-19 Risk Test across the United States.” ✓ confirmed on the page
  • A
    Genetic Technologies Ltd. 6-K filed 2021-04-26 Regulatory filing · published 26 Apr 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 910af7475211
    “The commercial release is expected to occur no later than the end of May once the technical interface for the United States telehealth platform is completed” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Product other
Indicative materiality
Low rules
Action
Make
Deliverable
COVID-19 PRS test
Language
Expected (“expects”, “plans”)
In the company’s control
Medium
Specificity
High
Conditional
Yes: subject to regulatory approvals
Depends on
Regulatory

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Not met”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Genetic Technologies Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-C166272-022596 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.